Not looking for an argument friend, that was my opinion at the time, so blame it on my magic 8 ball- neither I nor the magic ball are 100% correct. That being said, one can suppose/hope that BPMX has (wisely) been holding off on finalizing any JV decision until this crucial waiver was received- as it makes the prospect of approval in a timely manner much more feasible- the only thing (Ok, not only, but a major thing) that holds a stock down, particularly a speculative penny healthcare stock) is uncertainty. Today's news is a major step towards reducing (although not fully alleviating) uncertainty. To me, whether we are in the .30s-.40s (or .50s or .60s for that matter) next week or next month is of no great concern to me. I love bio/healthcare plays for the long term possibility of a big boom- having lived through such booms with EXEL (bought at less than $2) and TXMD (bough at less than $1) for just 2 examples, I am more than happy with continuing to wait for the real pay-day her, should it ever come!
